Priority Review

Priority Review is a process used by regulatory agencies, like the FDA, to evaluate a new medication or treatment more quickly than usual. When a company submits a drug for approval, it can request Priority Review if the drug addresses serious health conditions or offers significant benefits over existing options. If granted, the agency aims to complete their review within six months instead of the typical ten. This accelerated process helps patients access important new therapies faster, especially when they have limited treatment options or urgent medical needs.